Cargando…
De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning
The global pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) created a rush to discover drug candidates. Despite the efforts, so far no vaccine or drug has been approved for treatment. Artificial intelligence offers solutions that could...
Autores principales: | Santana, Marcos V. S., Silva-Jr, Floriano P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852053/ https://www.ncbi.nlm.nih.gov/pubmed/33531083 http://dx.doi.org/10.1186/s13065-021-00737-2 |
Ejemplares similares
-
Tuning proton transfer thermodynamics in SARS-Cov-2 main protease: implications for catalysis and inhibitor design
por: Zanetti-Polzi, Laura, et al.
Publicado: (2020) -
Tuning Proton Transfer Thermodynamics in SARS-CoV-2
Main Protease: Implications for Catalysis and Inhibitor Design
por: Zanetti-Polzi, Laura, et al.
Publicado: (2021) -
Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model
por: Morris, Aaron, et al.
Publicado: (2021) -
Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021) -
Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)